Dianthus Therapeutics (DNTH) Net Margin (2022 - 2025)

Dianthus Therapeutics' quarterly Net Margin came in at 9250.0% in Q3 2025, down 797026.0% year-on-year from N/an in Q3 2024, and up 43.37% quarter-over-quarter from 16333.68% in Q2 2025.

Dianthus Therapeutics has reported Net Margin for 4 years, with the latest figure at 9250.0% in Q3 2025.

  • For the quarter ending Q3 2025, Net Margin fell 797026.0% year-over-year to 9250.0%; the trailing twelve-month figure through Sep 2025 stood at 4027.8% (down 270885.0% YoY), and the FY2024 full-year result was 1355.24%, up 18086.0% from the prior year.
  • Net Margin for Q3 2025 stood at 9250.0%, up from 16333.68% in the prior quarter.
  • The five-year high for Net Margin was 668.2% in Q3 2022, with the low at 16333.68% in Q2 2025.
  • Average Net Margin over 4 years is 3248.8%, with a median of 1617.85% recorded in 2024.
  • Year-over-year, Net Margin surged 36157 bps in 2024 and slumped 1537190 bps in 2025.
  • Tracing DNTH's Net Margin over 4 years: stood at 868.13% in 2022, then plunged by 184 bps to 2467.61% in 2023, then rose by 15 bps to 2106.03% in 2024, then plunged by 339 bps to 9250.0% in 2025.
  • The last three Net Margin figures came in at 9250.0% (Q3 2025), 16333.68% (Q2 2025), and 2448.83% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 Dianthus Therapeutics 4.02 Bn 3.62 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -9,250.00%
Jun 30, 2025 -16,333.68%
Mar 31, 2025 -2,448.83%
Dec 31, 2024 -2,106.03%
Sep 30, 2024 -1,279.74%
Jun 30, 2024 -961.78%
Mar 31, 2024 -1,617.85%
Dec 31, 2023 -2,467.61%
Sep 30, 2023 -1,636.89%
Jun 30, 2023 -1,108.90%
Mar 31, 2023 -1,486.76%
Dec 31, 2022 -868.13%
Sep 30, 2022 -668.20%